This site is intended for healthcare professionals
Responding to unmet needs for metastatic castration-resistant prostate cancer
Responding to unmet needs for metastatic castration-resistant prostate cancer

ASCO GU 2024: mCRPC in focus

Read time: 10 mins
Last updated:15th Feb 2024
Published:2nd Feb 2024

From the ASCO Genitourinary Cancers Symposium 2024, read this summary of mCRPC clinical trial updates, including BRCAAway, CONTACT-02 and ACE.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Catch up with the latest thinking on treatment intensification in prostate cancer presented at the ASCO Genitourinary Cancers Symposium 2024.

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Expert-led assessment of relevant clinical guidance

Free scientific information and eLearning for healthcare professionals only

Including CME accreditation, podcasts, webinars and over 50 Learning Zones

Medthority is ad free, so you can learn without distraction

Welcome: